Quali-Tea with Anne

In this episode, the Quali-Tea team reflects on their predictions for 2024, discussing the accuracy of their forecasts regarding on-site audits, risk management, and the impact of AI in the pharmaceutical industry. They explore regulatory trends, investment dynamics, and emerging challenges, while also noting areas where their predictions fell short. The conversation highlights the evolving landsc...

In this enlightening conversation, Anne and Nu Trelle discuss the complexities of over-the-counter (OTC) medications, focusing on the regulations, approval processes, and the importance of compliance with OTC monographs. Nu Trelle shares insights from her extensive experience in the pharmaceutical industry, explaining the differences between OTC and prescription drugs, the significance of labeling...

In this conversation, Anne and Roger Smith delve into the world of robotic surgery and artificial intelligence, discussing the current landscape of surgical robots, the integration of AI in medical devices, and the regulatory challenges that accompany these advancements. They explore the implications of AI in surgical procedures, the role of independent robotic systems like the CyberKnife, and the...

In this conversation, Anne and Daniel Charles from Compliance Insight discuss the three types of FDA 510k submissions: traditional, special, and abbreviated. They explore the requirements, benefits, and trends associated with each submission type, emphasizing the importance of understanding the 510k process for medical device manufacturers. Daniel shares insights on the review process, common issu...

In this conversation, Anne and Michael Neece discuss the intricacies of handling difficult conversations, particularly in leadership and quality management contexts. They emphasize the importance of approaching these conversations with kindness, creating a safe environment, and being mindful of timing. Various feedback mechanisms are explored, including the sandwich principle and alternative metho...

In this conversation, Anne and Dia Hill discuss the FDA's final rule on laboratory developed tests (LDTs), focusing on the implications for the industry, the shift in regulation, and the challenges laboratories face in compliance. They explore the phased implementation timeline, the need for training and resources, and the importance of regulatory assessments and classification of tests. The conve...

In this conversation, Anne and Melissa discuss the modernization of cosmetic regulation, specifically the Modernization of Cosmetics Regulation Act (MoCRA) of 2022. They cover the scope of the act, which includes all personal care items, and the increased responsibility it places on cosmetic companies. They also discuss the history of cosmetic regulation, the motivation behind the modernization, a...

In this conversation, Anne, Bethan, Kim, and Carol discuss the qualities and interview questions to consider when hiring for positions in quality. They highlight the importance of communication skills, interpersonal awareness, technical writing skills, and experience in quality. They also emphasize the need for collaboration, a risk-based mindset, and the ability to make decisive decisions. The co...

Michael Neese, president of Our Future is Kind, discusses the importance of kindness in building a good quality culture. He emphasizes the role of emotional stakes in driving people's behavior and the need for leaders to be tuned into the invisible forces underlying interactions. Neese explains that kindness is not just a warm and fuzzy concept, but a critical part of business that can boost p...

In this conversation, the hosts discuss the qualifications and process of becoming an auditor. They share their own experiences and highlight the importance of practical training, mentorship, and formal certifications. They also discuss the documentation of auditor qualifications and the need for ongoing education and staying current with regulations. The conversation concludes with the benefits o...

In this episode, part two in the series on auditing. The hosts discuss the best way to close out an audit. Schedule time to organize your thoughts and findings before the closeout meeting Address all observations and findings with the auditee beforehand to avoid surprises Focus on the positive aspects and helpfulness of the employees Be professional, polite, and appreciative throughout the closeou...

In this conversation, Anne, Kim, and Steven discuss where to start when conducting an audit. They suggest asking for a list of deviations, change controls, and out-of-specifications (OOS) results before going on the tour. They also recommend requesting these lists in an Excel format for easier searching. Other starting points include reviewing batch records, the site validation master plan, the qu...

In this Q&A session, Anne answers questions about getting people on board with the value of quality incidents, handling a refusal to document changes, and managing audits efficiently. She suggests visually demonstrating the value of investigations and quantifying the cost of quality incidents to gain support. For documenting changes, she recommends simplifying the process, having change champi...

The conversation explores work-life balance for quality professionals and provides tips for managing it. The speakers discuss the importance of scheduling breaks, setting boundaries, and prioritizing tasks. They also emphasize the need for flexibility in quality roles due to unexpected events and global work. The conversation touches on the challenges of technology and the availability of work at...

The BIO International Convention covered a wide range of topics and trends in the biotech industry. Some of the key themes discussed include the growth of companies in the development and early phases of drug development, the importance of data integrity and documentation for regulatory compliance, the use of virtual reality and AI in training and drug development, and the advancements in diagnost...

The Day 3 Daily Update covers a range of topics from the Bio International Convention, including speaker talks, trends, regulatory insights, social events, and booth experiences. Melissa shares insights on the activities, trends, and interactions at the convention, providing valuable information on the industry's current landscape. Investor interest in new businesses and trends Growth of compa...

Troy Fugate discusses the Bio International Convention, focusing on compliance, quality, and industry trends. He emphasizes the importance of planning, procedures, and leadership in compliance, as well as the value of quality and regulatory teams for startups and biotech companies. Troy also highlights the presence of various countries and the interest of investors in the industry.

This week we have a special series of Daily Updates with the Compliance Insight consulting team live at the BIO International Convention in San Diego. In this daily update with Melissa Schneider, she provides insights into the Bio International Convention, highlighting the focus on the biologics space, the presence of contract manufacturing organizations, and the efforts of states and countries to...

In this conversation, Anne and Kim discuss the process of material qualification, covering topics such as the steps to take, considerations for new materials, challenges, and documentation requirements. They also touch on the importance of risk assessment and the impact of supplier qualification on material certification. Takeaways Material qualification and supplier qualification are two separate...

In this conversation, Anne MacNeil and Walter Wardrop discuss the leadership role in transformation and the importance of adequate resources. They highlight the key areas that leaders should focus on during a large transformation, such as understanding the change and its importance to the business. They emphasize the need for leaders to be inspirational and passionate about the change to build buy...

In this conversation, Anne and Kim discuss the different areas of supplier oversight, including supplier qualification, risk management, and continuous evaluation. They emphasize the importance of involving quality from the beginning in the vendor selection process and highlight the role of risk assessment in determining the level of qualification needed. They also discuss the next steps after sel...

In this first conversation of a two part series, Anne MacNeil and Walter Wardrop discuss the difference between process change and culture change. They emphasize the importance of defining the problem and understanding the root cause before implementing any changes. They also highlight the need to consider the people element and engage stakeholders early on to ensure buy-in and ownership of the ch...

"What is an acceptable level of quality?" In this conversation, Anne and Troy discuss the concept of acceptable quality level (AQL) and the importance of defining and understanding it. They highlight the need to consider the specific product and its intended use when determining the level of quality control. They also discuss the potential pitfalls of having too little or too much qualit...

In this episode, Anne and Kim discuss regulatory processes and submissions. They provide an overview of the CMC (Chemistry, Manufacturing, and Controls) template used in regulatory submissions. They also discuss the differences between brand new submissions and changes to existing submissions. The process of submitting changes for review and approval is explained, including the different types of...

In this episode, Anne, Kim, and Beth discuss data integrity and its importance in ensuring compliance. They highlight key trends, challenges, and requirements related to data integrity, including observations around quality control systems, access control, storage and backup of data, audit trails, and the process of invalidating data. They emphasize the need for periodic review of access control,...